Annual Total Debt
$266.17 M
+$5.22 M+2.00%
31 December 2023
Summary:
Esperion Therapeutics annual total debt is currently $266.17 million, with the most recent change of +$5.22 million (+2.00%) on 31 December 2023. During the last 3 years, it has risen by +$80.76 million (+43.56%). ESPR annual total debt is now at all-time high.ESPR Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$268.96 M
-$173.00 K-0.06%
30 September 2024
Summary:
Esperion Therapeutics quarterly total debt is currently $268.96 million, with the most recent change of -$173.00 thousand (-0.06%) on 30 September 2024. Over the past year, it has increased by +$4.83 million (+1.83%). ESPR quarterly total debt is now -2.75% below its all-time high of $276.55 million, reached on 31 March 2021.ESPR Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.0% | +1.8% |
| 3 y3 years | +43.6% | -2.6% |
| 5 y5 years | +100.0% | +10000.0% |
ESPR Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +43.6% | -2.6% | +3.4% |
| 5 y | 5 years | at high | -2.8% | >+9999.0% | |
| alltime | all time | at high | -2.8% |
Esperion Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $268.96 M(-0.1%) |
| June 2024 | - | $269.13 M(+0.1%) |
| Mar 2024 | - | $268.99 M(+1.1%) |
| Dec 2023 | $266.17 M(+2.0%) | $266.17 M(+0.8%) |
| Sept 2023 | - | $264.13 M(+0.4%) |
| June 2023 | - | $263.13 M(+0.7%) |
| Mar 2023 | - | $261.40 M(+0.2%) |
| Dec 2022 | $260.95 M(+0.3%) | $260.95 M(+0.3%) |
| Sept 2022 | - | $260.23 M(+0.0%) |
| June 2022 | - | $260.17 M(+0.0%) |
| Mar 2022 | - | $260.16 M(-0.0%) |
| Dec 2021 | $260.20 M(+40.3%) | $260.20 M(-5.8%) |
| Sept 2021 | - | $276.22 M(-0.1%) |
| June 2021 | - | $276.36 M(-0.1%) |
| Mar 2021 | - | $276.55 M(+49.2%) |
| Dec 2020 | $185.41 M(>+9900.0%) | $185.41 M(+2652.5%) |
| Sept 2020 | - | $6.74 M(+8.7%) |
| June 2020 | - | $6.20 M(+10.1%) |
| Mar 2020 | - | $5.63 M(+260.3%) |
| Dec 2019 | $1.56 M(>+9900.0%) | $1.56 M(+43.8%) |
| Sept 2019 | - | $1.09 M(+13.5%) |
| June 2019 | - | $958.00 K(-1.8%) |
| Mar 2019 | - | $976.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(-100.0%) |
| June 2018 | - | $152.00 K(-74.8%) |
| Mar 2018 | - | $603.00 K(-42.3%) |
| Dec 2017 | $1.04 M | $1.04 M(-29.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | $1.48 M(-22.3%) |
| June 2017 | - | $1.90 M(-18.0%) |
| Mar 2017 | - | $2.32 M(-15.0%) |
| Dec 2016 | $2.73 M(-36.4%) | $2.73 M(-12.8%) |
| Sept 2016 | - | $3.13 M(-11.2%) |
| June 2016 | - | $3.53 M(-9.8%) |
| Mar 2016 | - | $3.91 M(-8.9%) |
| Dec 2015 | $4.29 M(-11.9%) | $4.29 M(-7.9%) |
| Sept 2015 | - | $4.66 M(-4.9%) |
| June 2015 | - | $4.90 M(+0.3%) |
| Mar 2015 | - | $4.88 M(+0.3%) |
| Dec 2014 | $4.87 M(>+9900.0%) | $4.87 M(-1.2%) |
| Sept 2014 | - | $4.93 M(+0.1%) |
| June 2014 | - | $4.92 M(>+9900.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(-100.0%) |
| Dec 2012 | $22.77 M(+230.1%) | $22.77 M(>+9900.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00 |
| Dec 2011 | $6.90 M(-21.6%) | - |
| Dec 2002 | $8.79 M(+38.6%) | - |
| Dec 2001 | $6.34 M(+70.4%) | - |
| Dec 2000 | $3.72 M(+34.0%) | - |
| Dec 1999 | $2.78 M | - |
FAQ
- What is Esperion Therapeutics annual total debt?
- What is the all time high annual total debt for Esperion Therapeutics?
- What is Esperion Therapeutics annual total debt year-on-year change?
- What is Esperion Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly total debt year-on-year change?
What is Esperion Therapeutics annual total debt?
The current annual total debt of ESPR is $266.17 M
What is the all time high annual total debt for Esperion Therapeutics?
Esperion Therapeutics all-time high annual total debt is $266.17 M
What is Esperion Therapeutics annual total debt year-on-year change?
Over the past year, ESPR annual total debt has changed by +$5.22 M (+2.00%)
What is Esperion Therapeutics quarterly total debt?
The current quarterly total debt of ESPR is $268.96 M
What is the all time high quarterly total debt for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly total debt is $276.55 M
What is Esperion Therapeutics quarterly total debt year-on-year change?
Over the past year, ESPR quarterly total debt has changed by +$4.83 M (+1.83%)